Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. GRFS
GRFS logo

GRFS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Grifols SA (GRFS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.030
1 Day change
-2.07%
52 Week Range
11.140
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Grifols SA (GRFS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial growth in its latest quarter, the technical indicators are bearish, hedge funds are heavily selling, and there is no significant positive sentiment or event-driven catalyst. The options data also reflects a bearish sentiment. Given the lack of strong buy signals and the investor's preference for long-term stability, holding off on investing in GRFS is recommended for now.

Technical Analysis

The technical indicators for GRFS are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral, and the moving averages are aligned in a bearish pattern (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 8.904, with key support at 8.457 and resistance at 9.351.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
4

Positive Catalysts

  • The company's financial performance in Q3 2025 showed strong growth, with revenue up 10.68% YoY, net income up 161.30% YoY, and EPS up 175.00% YoY. This indicates operational improvements.

Neutral/Negative Catalysts

  • Hedge funds are heavily selling the stock, with a 986.97% increase in selling over the last quarter. The gross margin has decreased by 2.96% YoY. Analysts have lowered price targets, and there is no recent news or event-driven catalyst to drive positive sentiment.

Financial Performance

In Q3 2025, Grifols reported a revenue increase of 10.68% YoY to $2.18 billion, net income growth of 161.30% YoY to $148.4 million, and EPS growth of 175.00% YoY to $0.22. However, gross margin declined by 2.96% YoY to 39.33%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have a neutral stance on GRFS. JPMorgan recently lowered the price target from $10.30 to $10 and from EUR 9 to EUR 8.50, citing concerns about the lack of pipeline readouts in 2026. This reflects a cautious outlook on the stock's future performance.

Wall Street analysts forecast GRFS stock price to rise
Analyst Rating
0
Wall Street analysts forecast GRFS stock price to rise
Buy
Hold
Sell
0
Current: 8.200
sliders
Low
0
Averages
0
High
0
0
Current: 8.200
sliders
Low
0
Averages
0
High
0
Morgan Stanley
Overweight -> Equal Weight
downgrade
AI Analysis
2026-03-10
New
Reason
Morgan Stanley
Price Target
AI Analysis
2026-03-10
New
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded Grifols to Equal Weight from Overweight with a price target of EUR 11, down from EUR 14. The firm cites uncertainties around the company's revenue growth amid the albumin and alpha-1 slowdown. Decaling albumin sales in China and the slowdown of alpha-1 are leading Grifols to limit volume growth in 2026 to protect margins, the analyst tells investors in a research note.
JPMorgan
Neutral
downgrade
$10
2025-12-08
Reason
JPMorgan
Price Target
$10
2025-12-08
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Grifols to $10 from $10.30 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the European pharma group as part of its 2026 outlook. It expects sector performance to be driven by pipeline readouts, saying much of the concern around the impact of U.S. price pressure on sector earnings has dissipated in Q4. JPMorgan downgraded companies with a lack of pipeline readouts in 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GRFS
Unlock Now

People Also Watch